miRNA Sequencing & Assay Market by Product & Service (Products, Services), Technology (Nanopore Sequencing, Sanger Sequencing, Sequencing By Oligonucleotide Ligation & Detection), Workflow, End-User, Application - Global Forecast 2024-2030

miRNA Sequencing & Assay Market by Product & Service (Products, Services), Technology (Nanopore Sequencing, Sanger Sequencing, Sequencing By Oligonucleotide Ligation & Detection), Workflow, End-User, Application - Global Forecast 2024-2030


The miRNA Sequencing & Assay Market size was estimated at USD 333.35 million in 2023 and expected to reach USD 380.21 million in 2024, at a CAGR 14.15% to reach USD 841.92 million by 2030.

Global miRNA Sequencing & Assay Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the miRNA Sequencing & Assay Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the miRNA Sequencing & Assay Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the miRNA Sequencing & Assay Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Bio-Rad Laboratories, Inc., Global Life Sciences Solutions USA LLC, HTG Molecular Diagnostics, Inc., Illumina, Inc., Integrated DNA Technologies, Inc, Lexogen GmbH, Meridian Bioscience Inc, New England Biolabs (UK) Ltd., Norgen Biotek Corp., Oxford Nanopore Technologies Limited, Rosetta Genomics Ltd., Sigma Aldrich Corp., System Biosciences, LLC, Thermo Fisher Scientific Inc., and TriLink BioTechnologies, Inc..

Market Segmentation & Coverage

This research report categorizes the miRNA Sequencing & Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product & Service
Products
Instruments
Library Preparation Kits
Sequencing Consumables
Services
Technology
Nanopore Sequencing
Sanger Sequencing
Sequencing By Oligonucleotide Ligation & Detection
Single Molecule Real-Time (SMRT) Sequencing
Workflow
Data Analysis & Storage
Library Preparation
Sequencing
End-User
Contract Research Organizations
Pharmaceutical & Biotechnology Industry
Research & Academic Institutes
Application
Autoimmune Disease
Cancer
Polyglutamine Diseases
Schizophrenia
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the miRNA Sequencing & Assay Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the miRNA Sequencing & Assay Market?
3. What are the technology trends and regulatory frameworks in the miRNA Sequencing & Assay Market?
4. What is the market share of the leading vendors in the miRNA Sequencing & Assay Market?
5. Which modes and strategic moves are suitable for entering the miRNA Sequencing & Assay Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. miRNA Sequencing & Assay Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Introduction of various techniques to assess the miRNA sequence
5.1.1.2. Increased prevalence of infectious diseases
5.1.1.3. Surge in the number of cancer incidences
5.1.2. Restraints
5.1.2.1. Lack of skilled professionals
5.1.3. Opportunities
5.1.3.1. Growing popularity for cost effective sequencing techniques
5.1.3.2. Increase in the number of research in genetic segment
5.1.4. Challenges
5.1.4.1. High initial investment on infrastructure
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. miRNA Sequencing & Assay Market, by Product & Service
6.1. Introduction
6.2. Products
6.3.1. Instruments
6.3.2. Library Preparation Kits
6.3.3. Sequencing Consumables
6.3. Services
7. miRNA Sequencing & Assay Market, by Technology
7.1. Introduction
7.2. Nanopore Sequencing
7.3. Sanger Sequencing
7.4. Sequencing By Oligonucleotide Ligation & Detection
7.5. Single Molecule Real-Time (SMRT) Sequencing
8. miRNA Sequencing & Assay Market, by Workflow
8.1. Introduction
8.2. Data Analysis & Storage
8.3. Library Preparation
8.4. Sequencing
9. miRNA Sequencing & Assay Market, by End-User
9.1. Introduction
9.2. Contract Research Organizations
9.3. Pharmaceutical & Biotechnology Industry
9.4. Research & Academic Institutes
10. miRNA Sequencing & Assay Market, by Application
10.1. Introduction
10.2. Autoimmune Disease
10.3. Cancer
10.4. Polyglutamine Diseases
10.5. Schizophrenia
11. Americas miRNA Sequencing & Assay Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific miRNA Sequencing & Assay Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa miRNA Sequencing & Assay Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Abcam PLC
15.1.2. Bio-Rad Laboratories, Inc.
15.1.3. Global Life Sciences Solutions USA LLC
15.1.4. HTG Molecular Diagnostics, Inc.
15.1.5. Illumina, Inc.
15.1.6. Integrated DNA Technologies, Inc
15.1.7. Lexogen GmbH
15.1.8. Meridian Bioscience Inc
15.1.9. New England Biolabs (UK) Ltd.
15.1.10. Norgen Biotek Corp.
15.1.11. Oxford Nanopore Technologies Limited
15.1.12. Rosetta Genomics Ltd.
15.1.13. Sigma Aldrich Corp.
15.1.14. System Biosciences, LLC
15.1.15. Thermo Fisher Scientific Inc.
15.1.16. TriLink BioTechnologies, Inc.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. MIRNA SEQUENCING & ASSAY MARKET RESEARCH PROCESS
FIGURE 2. MIRNA SEQUENCING & ASSAY MARKET SIZE, 2023 VS 2030
FIGURE 3. MIRNA SEQUENCING & ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. MIRNA SEQUENCING & ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MIRNA SEQUENCING & ASSAY MARKET DYNAMICS
FIGURE 7. MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
FIGURE 8. MIRNA SEQUENCING & ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. MIRNA SEQUENCING & ASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
FIGURE 12. MIRNA SEQUENCING & ASSAY MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. MIRNA SEQUENCING & ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 16. MIRNA SEQUENCING & ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES MIRNA SEQUENCING & ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MIRNA SEQUENCING & ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. MIRNA SEQUENCING & ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. MIRNA SEQUENCING & ASSAY MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings